A detailed history of Blodgett Wealth Advisors, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Blodgett Wealth Advisors, LLC holds 14,442 shares of PFE stock, worth $412,463. This represents 0.34% of its overall portfolio holdings.

Number of Shares
14,442
Previous 15,021 3.85%
Holding current value
$412,463
Previous $416,000 2.88%
% of portfolio
0.34%
Previous 0.38%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 23, 2024

SELL
$25.26 - $29.6 $14,625 - $17,138
-579 Reduced 3.85%
14,442 $404,000
Q1 2024

Apr 22, 2024

SELL
$25.89 - $29.73 $56,310 - $64,662
-2,175 Reduced 12.65%
15,021 $416,000
Q4 2023

Feb 02, 2024

SELL
$26.13 - $33.94 $566,942 - $736,396
-21,697 Reduced 55.79%
17,196 $495,000
Q3 2023

Oct 27, 2023

SELL
$32.09 - $37.51 $80,128 - $93,662
-2,497 Reduced 6.03%
38,893 $1.29 Million
Q2 2023

Jul 26, 2023

BUY
$36.12 - $41.79 $1,842 - $2,131
51 Added 0.12%
41,390 $1.52 Million
Q1 2023

Apr 21, 2023

SELL
$39.39 - $51.28 $17,646 - $22,973
-448 Reduced 1.07%
41,339 $1.69 Million
Q4 2022

Feb 02, 2023

BUY
$41.75 - $54.5 $8,433 - $11,009
202 Added 0.49%
41,787 $2.14 Million
Q3 2022

Oct 21, 2022

BUY
$43.76 - $53.42 $21,967 - $26,816
502 Added 1.22%
41,585 $1.82 Million
Q2 2022

Jul 20, 2022

SELL
$46.53 - $55.17 $23,171 - $27,474
-498 Reduced 1.2%
41,083 $2.15 Million
Q1 2022

Apr 27, 2022

BUY
$45.75 - $56.69 $4,575 - $5,669
100 Added 0.24%
41,581 $2.15 Million
Q4 2021

Feb 02, 2022

BUY
$41.32 - $61.25 $1.71 Million - $2.54 Million
41,481 New
41,481 $2.45 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $160B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Blodgett Wealth Advisors, LLC Portfolio

Follow Blodgett Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blodgett Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Blodgett Wealth Advisors, LLC with notifications on news.